| Shu, Qiang |
NCT02837978: The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment |
|
|
| Completed | 4 | 150 | RoW | Tacrolimus, FK506, MTX, methotrexate | Qiang Shu | Arthritis, Rheumatoid | 09/22 | 12/22 | | |
SMART, NCT06722586: Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia |
|
|
| Recruiting | 3 | 84 | RoW | Sirolimus, Rapamycin, mTOR inhibitor, Placebo | Peking University First Hospital, North China Pharmaceutical Co.,Ltd | Antiphospholipid (aPL)-positive, Thrombocytopaenia | 12/27 | 12/27 | | |
| Recruiting | 2/3 | 240 | Europe, Canada, Japan, US, RoW | EFG PH20 SC, PBO | argenx, argenx BV | Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome | 12/26 | 02/27 | | |
NCT05614531: Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 |
|
|
| Enrolling by invitation | 1/2 | 12 | RoW | EXG001-307 injection | Hangzhou Jiayin Biotech Ltd | Spinal Muscular Atrophy Type I | 08/25 | 08/25 | | |
NCT05247203: Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus |
|
|
| Completed | 1 | 92 | RoW | Telitacicept, RC18, standard therapy | RemeGen Co., Ltd. | Systemic Lupus Erythematosus | 10/23 | 11/23 | | |
NCT06144710: SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 48 | RoW | SG301 SC Injection, SG301 SC Placebo | Hangzhou Sumgen Biotech Co., Ltd. | Systemic Lupus Erythematosus (SLE) | 05/25 | 10/25 | | |
| Recruiting | 1 | 12 | RoW | VGM-R02b, rAAV9-GCDH | Shanghai Vitalgen BioPharma Co., Ltd. | Glutaric Acidemia Type I, Glutaric Aciduria Type I | 08/26 | 08/26 | | |
| Recruiting | N/A | 2000 | RoW | | Peking Union Medical College Hospital | Anti Phospholipid Syndrome | 12/26 | 12/26 | | |
| Mao, Jianhua |
STAMP, NCT04048161: Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome |
|
|
| Completed | 4 | 270 | RoW | Tacrolimus, Tacrolimus capsules（CYONSE®）, Mycophenolate Mofetil, Mycophenolate Mofetil Dispersible tablets（CYCOPIN®） | The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Fudan University, Peking University First Hospital, First Affiliated Hospital of Zhongshan Medical University, Nanjing Children's Hospital, Chengdu Women and Children's Center Hospital, Tongji Hospital, Second Xiangya Hospital of Central South University, Children's Hospital of Chongqing Medical University, Children's Hospital of Soochow University, Henan Provincial People's Hospital, Shandong Provincial Hospital | Nephrotic Syndrome in Children | 05/23 | 07/23 | | |
NCT05772871: The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children |
|
|
| Recruiting | 4 | 402 | RoW | Huaiqihuang granule, Prednisone, Levamisole placebo, Levamisole, Huaiqihuang Granule placebo | Jianhua Zhou, LinkDoc Technology (Beijing) Co. Ltd. | Nephrotic Syndrome in Children | 09/25 | 10/25 | | |
STERN, NCT06125405: Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome |
|
|
| Recruiting | 3 | 20 | RoW | Telitacicept | The Children's Hospital of Zhejiang University School of Medicine | Nephrotic Syndrome in Children, Telitacicept | 10/26 | 10/27 | | |
NCT06222853: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 18 | RoW | anti-CD19-CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine, Chongqing Precision Biotech Co., Ltd | Systemic Lupus Erythematosus, CAR-T Cell Therapy | 12/26 | 12/26 | | |
NCT06553898: Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS |
|
|
| Recruiting | 1 | 18 | RoW | anti-BCMA/CD70 CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine | Multi-Drug Resistant Nephrotic Syndrome, CAR-T Cell Therapy | 07/25 | 07/27 | | |
NCT06607991: Blinatumomab for CNI-Resistant/Intolerant SRNS in Children |
|
|
| Recruiting | 1 | 6 | RoW | Blinatumomab Treatment | The Children's Hospital of Zhejiang University School of Medicine | CNI-resistant Steriod Resistant Nephrotic Syndrome, CNI-intolerent, Steriod Resistant Nephrotic Syndrome | 09/25 | 09/27 | | |
SLE, NCT06691152: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus |
|
|
| Recruiting | 1 | 18 | RoW | CD19 Universal CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine | Systemic Lupus Erythematosus | 09/27 | 09/27 | | |
SEEK, NCT06792799: Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease |
|
|
| Not yet recruiting | 1 | 72 | RoW | anti-CD19/BCMA CAR NK cells (KN5601) | The Children's Hospital of Zhejiang University School of Medicine | Autoimmune Diseases, Systemic Lupus Erthematosus, Multi-Drug Resistant Nephrotic Syndrome | 06/28 | 06/29 | | |
NCT06508346: Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV |
|
|
| Recruiting | N/A | 12 | RoW | anti-CD19-CAR-T cells | The Children's Hospital of Zhejiang University School of Medicine, Children's Hospital of Chongqing Medical University | ANCA Associated Vasculitis, CAR-T Cell Therapy | 07/26 | 07/27 | | |
NCT06539624: Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease |
|
|
| Recruiting | N/A | 12 | RoW | EXG110 injection | The Children's Hospital of Zhejiang University School of Medicine | Fabry Disease | 04/27 | 04/27 | | |
| Wang, Jingjing |
| Recruiting | 4 | 180 | RoW | Simvastatin combined with Amlodipine besylate, Simvastatin combined with Spironolactone and Amlodipine besylate., Amlodipine besylate combined Spironolactone | Third Military Medical University | Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension | 12/25 | 09/26 | | |
NCT06354530: A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Recruiting | 2/3 | 266 | RoW | anlotinib, Thoracic radiotherapy, radiotherapy | Army Medical Center of PLA | Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma | 12/25 | 12/26 | | |
NCT06241781: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer |
|
|
| Recruiting | 2 | 64 | RoW | GT101 injection, Gemcitabine injection | Grit Biotechnology | Adult | 01/27 | 01/27 | | |
RWS-MTB, NCT06781151: A Study to Explore Personalized Treatment for Patients with Recurrent Gynecological Malignancies Based on MTB |
|
|
| Recruiting | N/A | 200 | RoW | | Sun Yat-sen University | Ovarian Cancer Recurrent, Endometrial Cancer Recurrent, Cervical Cancer Recurrent | 12/26 | 06/27 | | |
NCT05454878: Atrial Fibrillation Monitoring on Patients With Lymphoma After Chemotherapy |
|
|
| Not yet recruiting | N/A | 100 | RoW | | Chinese PLA General Hospital | Atrial Fibrillation | 07/23 | 12/23 | | |
